Latest Share Purchase Plan News

GR Engineering Services secured $100 million through a heavily supported institutional placement priced at $6.10 per share, alongside a $10 million Share Purchase Plan for retail investors. The capital raise aims to bolster the balance sheet ahead of a busy contract delivery phase.

TALi Digital Limited (ASX: TD1) posted a 416% jump in revenue for FY26 but also recorded a $2.2 million loss driven by a $1.3 million impairment of its YCDI! intangible assets. The company is pursuing growth through AI-focused acquisitions and a $3.3 million capital raise.

Prescient Therapeutics (ASX:PTX) has opened a $7 million Share Purchase Plan at a significant discount to advance its lead cancer therapy PTX-100 beyond a pivotal Dose Optimisation Committee review in late 2026.

Paladin Energy Ltd (ASX:PDN) reversed prior losses with a net profit of US$5.3 million in FY2026, driven by a strong ramp-up of uranium production at Namibia's Langer Heinrich Mine and regulatory progress at its Canadian Patterson Lake South Project.

Prescient Therapeutics launches a $7 million Share Purchase Plan at an 18.8% discount to fund advancement of its PTX-100 cancer therapy beyond a key 2026 Dose Optimisation Committee review.

Hawsons Iron Limited has closed its Share Purchase Plan raising $1.23 million through the issuance of 111.82 million shares at $0.011 each, accompanied by free attaching options. Directors contributed $90,000, reinforcing alignment with shareholders.

AUB Group delivered a robust FY26 with 12.2% underlying NPAT growth to $224.6 million, driven by strong international and domestic performances, and completed its strategic UK Prestige acquisition. The company declared a fully franked 71-cent final dividend and provided positive FY27 profit guidance.

GR Engineering Services delivered a record EBITDA of $63.1 million in FY26, secured over $1 billion in new contracts, and announced a $110 million equity raise to support a forecast revenue surge in FY27.

TALi Digital is acquiring Datasphere Analytics to access cutting-edge memristive in-memory computing technology, aiming to enhance its AI-driven education platform. The company is concurrently raising $3.3 million to fund this strategic move and ongoing operations.

Cyclopharm Limited posted a fifth consecutive record half-year revenue of $17.5 million, propelled by a 74% jump in US Technegas® sales and a doubling of revenue-generating US sites. New US clinical guidelines naming Technegas® as the preferred ventilation imaging agent underpin a robust growth outlook despite a wider net loss.

True North Copper Limited (ASX:TNC) has opened a Share Purchase Plan allowing eligible shareholders to buy up to $30,000 of shares at $0.37 each, a 14% discount to recent trading prices. The SPP complements an institutional placement, targeting a combined raise of $20 million to fund the Mt Oxide Copper Project.

WAM Income Maximiser posted a robust 19.2% investment portfolio gain in FY2026, outperforming its benchmark by 13.4%, while raising fully franked dividends and launching a new entitlement offer to fuel further growth.